Search hospitals > Kentucky > Corbin
Baptist Health Corbin
Claim this profileCorbin, Kentucky 40701
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
53 reported clinical trials
8 medical researchers
Summary
Baptist Health Corbin is a medical facility located in Corbin, Kentucky. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Baptist Health Corbin is involved with conducting 53 clinical trials across 129 conditions. There are 8 research doctors associated with this hospital, such as Firas Badin, MD, Hope Cottrill, Lee Hicks, and Wangjian Zhong.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Firas Badin, MDBaptist Health Lexington4 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
23 drugs studied
Hope CottrillBaptist Health Lexington1 year of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
9 reported clinical trials
23 drugs studied
Lee HicksBaptist Health Lexington6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
8 reported clinical trials
22 drugs studied
Wangjian ZhongBaptist Health Louisville4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
8 reported clinical trials
21 drugs studied
Clinical Trials running at Baptist Health Corbin
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Baptist Health Corbin?
Baptist Health Corbin is a medical facility located in Corbin, Kentucky. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Baptist Health Corbin is involved with conducting 53 clinical trials across 129 conditions. There are 8 research doctors associated with this hospital, such as Firas Badin, MD, Hope Cottrill, Lee Hicks, and Wangjian Zhong.